$2.76 Billion is the total value of Rock Springs Capital Management LP's 135 reported holdings in Q2 2019. The portfolio turnover from Q1 2019 to Q2 2019 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| UNH | UNITEDHEALTH GROUP INC | $144,210,000 | -1.3% | 591,000 | 0.0% | 5.22% | -7.4% | |
| AMRN | AMARIN CORP PLCspons adr new | $87,740,000 | -6.6% | 4,525,000 | 0.0% | 3.17% | -12.4% | |
| ISRG | INTUITIVE SURGICAL INC | $79,994,000 | -8.1% | 152,500 | 0.0% | 2.89% | -13.7% | |
| HCA | HCA HEALTHCARE INC | $61,502,000 | +3.7% | 455,000 | 0.0% | 2.22% | -2.7% | |
| PCRX | PACIRA BIOSCIENCES | $54,363,000 | +14.3% | 1,250,000 | 0.0% | 1.97% | +7.3% | |
| EXAS | EXACT SCIENCES CORP | $46,862,000 | +36.3% | 397,000 | 0.0% | 1.70% | +27.8% | |
| TFX | TELEFLEX INC | $43,050,000 | +9.6% | 130,000 | 0.0% | 1.56% | +2.8% | |
| BSX | BOSTON SCIENTIFIC CORP | $41,691,000 | +12.0% | 970,000 | 0.0% | 1.51% | +5.1% | |
| IRTC | IRHYTHM TECHNOLOGIES INC | $39,510,000 | +5.5% | 499,615 | 0.0% | 1.43% | -1.0% | |
| VRTX | VERTEX PHARMACEUTICALS INC | $37,226,000 | -0.3% | 203,000 | 0.0% | 1.35% | -6.5% | |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | $36,830,000 | -8.4% | 580,000 | 0.0% | 1.33% | -14.1% | |
| SYK | STRYKER CORP | $36,799,000 | +4.1% | 179,000 | 0.0% | 1.33% | -2.3% | |
| EW | EDWARDS LIFESCIENCES CORP | $33,900,000 | -3.4% | 183,500 | 0.0% | 1.23% | -9.5% | |
| IDXX | IDEXX LABS INC | $33,095,000 | +23.1% | 120,200 | 0.0% | 1.20% | +15.5% | |
| ALXN | ALEXION PHARMACEUTICALS INC | $31,763,000 | -3.1% | 242,500 | 0.0% | 1.15% | -9.1% | |
| ALGN | ALIGN TECHNOLOGY INC | $28,739,000 | -3.7% | 105,000 | 0.0% | 1.04% | -9.6% | |
| BGNE | BEIGENE LTDsponsored adr | $26,624,000 | -6.1% | 214,800 | 0.0% | 0.96% | -11.9% | |
| INCY | INCYTE CORP | $26,533,000 | -1.2% | 312,300 | 0.0% | 0.96% | -7.3% | |
| ARGX | ARGENX SEsponsored adr | $25,725,000 | +13.4% | 181,700 | 0.0% | 0.93% | +6.4% | |
| BAX | BAXTER INTL INC | $24,627,000 | +0.7% | 300,700 | 0.0% | 0.89% | -5.5% | |
| ASND | ASCENDIS PHARMA A Ssponsored adr | $24,585,000 | -2.2% | 213,500 | 0.0% | 0.89% | -8.3% | |
| RARX | RA PHARMACEUTICALS INC | $24,176,000 | +34.2% | 804,000 | 0.0% | 0.88% | +26.1% | |
| PRAH | PRA HEALTH SCIENCES INC | $23,796,000 | -10.1% | 240,000 | 0.0% | 0.86% | -15.7% | |
| TMO | THERMO FISHER SCIENTIFIC INC | $23,788,000 | +7.3% | 81,000 | 0.0% | 0.86% | +0.7% | |
| BIIB | BIOGEN INCcall | $22,802,000 | -1.1% | 97,500 | 0.0% | 0.82% | -7.2% | |
| GLPG | GALAPAGOS NVspon adr | $21,273,000 | +9.5% | 165,000 | 0.0% | 0.77% | +2.8% | |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $20,749,000 | -13.1% | 1,577,893 | 0.0% | 0.75% | -18.5% | |
| ALLK | ALLAKOS INC | $17,505,000 | +7.0% | 404,000 | 0.0% | 0.63% | +0.3% | |
| CELG | CELGENE CORP | $17,115,000 | -2.0% | 185,150 | 0.0% | 0.62% | -8.0% | |
| SAGE | SAGE THERAPEUTICS INC | $16,936,000 | +15.1% | 92,500 | 0.0% | 0.61% | +8.1% | |
| SGEN | SEATTLE GENETICS INC | $16,749,000 | -5.5% | 242,000 | 0.0% | 0.61% | -11.3% | |
| AXNX | AXONICS MODULATION TECH INC | $16,388,000 | +71.1% | 400,000 | 0.0% | 0.59% | +60.7% | |
| FGEN | FIBROGEN INC | $13,825,000 | -16.9% | 306,000 | 0.0% | 0.50% | -22.0% | |
| A | AGILENT TECHNOLOGIES INC | $13,650,000 | -7.1% | 182,800 | 0.0% | 0.49% | -12.7% | |
| TBIO | TRANSLATE BIO INC | $12,746,000 | +23.9% | 1,009,179 | 0.0% | 0.46% | +16.4% | |
| OBSV | OBSEVA SA | $12,667,000 | -11.6% | 1,120,000 | 0.0% | 0.46% | -17.0% | |
| FOLD | AMICUS THERAPEUTICS INC | $12,480,000 | -8.2% | 1,000,000 | 0.0% | 0.45% | -13.7% | |
| NVCR | NOVOCURE LTD | $12,330,000 | +31.3% | 195,000 | 0.0% | 0.45% | +23.2% | |
| AXGN | AXOGEN INC | $11,959,000 | -6.0% | 603,970 | 0.0% | 0.43% | -11.6% | |
| ZGNX | ZOGENIX INC | $11,228,000 | -13.1% | 235,000 | 0.0% | 0.41% | -18.5% | |
| RIGL | RIGEL PHARMACEUTICALS INC | $10,962,000 | +1.6% | 4,200,000 | 0.0% | 0.40% | -4.6% | |
| FRPT | FRESHPET INC | $10,695,000 | +7.6% | 235,000 | 0.0% | 0.39% | +1.0% | |
| TBPH | THERAVANCE BIOPHARMA INC | $8,982,000 | -28.0% | 550,000 | 0.0% | 0.32% | -32.4% | |
| RTIX | RTI SURGICAL HOLDINGS INC | $8,288,000 | -29.3% | 1,950,000 | 0.0% | 0.30% | -33.6% | |
| DERM | DERMIRA INC | $7,409,000 | -29.4% | 775,000 | 0.0% | 0.27% | -33.8% | |
| SPRO | SPERO THERAPEUTICS INC | $6,043,000 | -10.1% | 525,000 | 0.0% | 0.22% | -15.4% | |
| INSMED INCnote 1.750% 1/1 | $5,849,000 | -3.8% | 6,000,000 | 0.0% | 0.21% | -9.4% | ||
| MRSN | MERSANA THERAPEUTICS INC | $5,670,000 | -23.0% | 1,400,000 | 0.0% | 0.20% | -27.8% | |
| ANTM | ANTHEM INC | $5,644,000 | -1.7% | 20,000 | 0.0% | 0.20% | -7.7% | |
| AGLE | AEGLEA BIOTHERAPEUTICS INC | $5,480,000 | -14.9% | 800,000 | 0.0% | 0.20% | -20.2% | |
| ARDX | ARDELYX INC | $5,380,000 | -3.9% | 2,000,000 | 0.0% | 0.20% | -9.7% | |
| CO | GLOBAL CORD BLOOD CORPORATIO | $5,347,000 | -17.7% | 925,000 | 0.0% | 0.19% | -22.8% | |
| MGNX | MACROGENICS INC | $5,091,000 | -5.6% | 300,000 | 0.0% | 0.18% | -11.5% | |
| MEDICINES COnote 2.750% 7/1 | $5,026,000 | +18.8% | 5,000,000 | 0.0% | 0.18% | +11.7% | ||
| MNTA | MOMENTA PHARMACEUTICALS INC | $4,980,000 | -14.3% | 400,000 | 0.0% | 0.18% | -19.6% | |
| CHMA | CHIASMA INC | $4,856,000 | +43.7% | 650,000 | 0.0% | 0.18% | +35.4% | |
| ALDER BIOPHARMACEUTICALS INCnote 2.500% 2/0 | $4,672,000 | -2.6% | 5,000,000 | 0.0% | 0.17% | -8.6% | ||
| CGEN | COMPUGEN LTDord | $4,224,000 | -7.2% | 1,100,000 | 0.0% | 0.15% | -13.1% | |
| TORC | RESTORBIO INC | $4,080,000 | +49.6% | 400,000 | 0.0% | 0.15% | +41.0% | |
| NABRIVA THERAPEUTICS PLC | $3,888,000 | -0.4% | 1,600,000 | 0.0% | 0.14% | -6.6% | ||
| CLVS | CLOVIS ONCOLOGY INC | $3,807,000 | -40.1% | 256,000 | 0.0% | 0.14% | -43.7% | |
| MEDICINES COnote 2.500% 1/1 | $3,618,000 | +20.1% | 3,000,000 | 0.0% | 0.13% | +12.9% | ||
| ARVN | ARVINAS INC | $3,299,000 | +49.0% | 150,000 | 0.0% | 0.12% | +40.0% | |
| CORV | CORREVIO PHARMA CORP | $2,592,000 | -31.6% | 1,200,000 | 0.0% | 0.09% | -35.6% | |
| PRTK | PARATEK PHARMACEUTICALS INC | $1,796,000 | -25.5% | 450,000 | 0.0% | 0.06% | -30.1% | |
| CRVS | CORVUS PHARMACEUTICALS INC | $1,496,000 | -7.0% | 400,000 | 0.0% | 0.05% | -12.9% | |
| RADIUS HEALTH INCnote 3.000% 9/0 | $1,361,000 | +9.0% | 1,500,000 | 0.0% | 0.05% | +2.1% | ||
| NEUROCRINE BIOSCIENCES INCnote 2.250% 5/1 | $1,317,000 | -2.7% | 1,000,000 | 0.0% | 0.05% | -7.7% | ||
| THERAVANCE BIOPHARMA INCnote 3.250%11/0 | $1,290,000 | -11.5% | 1,500,000 | 0.0% | 0.05% | -16.1% | ||
| KLDO | KALEIDO BIOSCIENCES INC | $1,161,000 | -20.0% | 100,050 | 0.0% | 0.04% | -25.0% | |
| PACIRA BIOSCIENCESnote 2.375% 4/0 | $1,026,000 | +4.0% | 1,000,000 | 0.0% | 0.04% | -2.6% | ||
| DERMIRA INCnote 3.000% 5/1 | $865,000 | -2.6% | 1,000,000 | 0.0% | 0.03% | -8.8% | ||
| PTI | PROTEOSTASIS THERAPEUTICS IN | $390,000 | -22.6% | 400,000 | 0.0% | 0.01% | -26.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.4% |
| NEUROCRINE BIOSCIENCES INC | 39 | Q3 2023 | 4.8% |
| PACIRA PHARMACEUTICALS INC | 39 | Q3 2023 | 2.6% |
| ULTRAGENYX PHARMACEUTICAL IN | 39 | Q3 2023 | 1.9% |
| ACADIA HEALTHCARE COMPANY IN | 38 | Q3 2023 | 4.4% |
| ASCENDIS PHARMA A/S | 35 | Q3 2023 | 1.3% |
| INVITAE CORP | 35 | Q3 2023 | 1.8% |
| BIOMARIN PHARMACEUTICAL INC | 35 | Q3 2023 | 1.3% |
| MACROGENICS INC | 35 | Q3 2023 | 0.5% |
| COLLEGIUM PHARMACEUTICAL INC | 34 | Q3 2023 | 2.1% |
View Rock Springs Capital Management LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Aeglea BioTherapeutics, Inc. | February 14, 2023 | 3,413,906 | 5.6% |
| Compass Therapeutics, Inc. | February 14, 2023 | 5,333,188 | 4.2% |
| Mirum Pharmaceuticals, Inc. | February 14, 2023 | 1,795,733 | 4.9% |
| PhaseBio Pharmaceuticals IncSold out | February 14, 2023 | 0 | 0.0% |
| Sierra Oncology, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| ARDELYX, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| CHIASMA, INCSold out | February 15, 2022 | 0 | 0.0% |
| FIVE PRIME THERAPEUTICS, INC.Sold out | February 15, 2022 | 0 | 0.0% |
| F-star Therapeutics, Inc. | February 15, 2022 | 751,889 | 3.6% |
| Protara Therapeutics, Inc.Sold out | February 15, 2022 | 0 | 0.0% |
View Rock Springs Capital Management LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G | 2024-05-01 |
| SC 13G/A | 2024-04-05 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
View Rock Springs Capital Management LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.